Blood Glucose Monitoring Devices Market Share & Size Report 2029F

Report Description

Forecast Period	2025-2029
Market Size (2023)	USD 18.88 Billion
CAGR (2024-2029)	7.09%
Fastest Growing Segment	Self-Monitoring Devices
Largest Market	North America

Market Overview

Global Glucose Monitoring Device Market has valued at USD 18.88 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.09% through 2029. The glucose monitoring device market is propelled by the increasing prevalence of diabetes worldwide and continual technological advancements. Innovations in wearable and non-invasive monitoring devices, coupled with a growing awareness of diabetes management, drive market expansion. Rising healthcare expenditure, an aging population, and the surge in remote patient monitoring practices further contribute to market growth. Government initiatives, supportive regulations, and patient preferences for user-friendly solutions also play pivotal roles. As the market integrates with broader healthcare ecosystems, and with a focus on emerging economies, the glucose monitoring device market is poised for sustained expansion, addressing the evolving needs of diabetes management.

Key Market Drivers

Increasing Prevalence of Diabetes

The escalating global prevalence of diabetes is a paramount factor propelling the growth of the glucose monitoring device market. Diabetes, a chronic metabolic disorder characterized by elevated blood sugar levels, has reached epidemic proportions, affecting millions of individuals worldwide. The surge in diabetes cases is attributed to factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions.

As the diabetic population continues to expand, the demand for efficient and accessible glucose monitoring solutions intensifies. Glucose monitoring devices play a crucial role in enabling individuals to track and manage their blood glucose levels, aiding in timely interventions and personalized treatment plans. The prevalence of diabetes is particularly high in both developed and developing nations, emphasizing the global nature of this health challenge.

Healthcare providers, pharmaceutical companies, and technology developers are actively addressing the diabetes epidemic by introducing advanced monitoring technologies. These innovations include continuous glucose monitoring (CGM) systems, smart insulin pens, and wearable devices that provide real-time data and insights. The imperative to manage diabetes effectively to prevent complications and enhance the quality of life underscores the significance of glucose monitoring devices in modern healthcare, making them a focal point in the evolving landscape of chronic disease management.

Technological Advancements

Technological advancements constitute a pivotal factor driving the growth of the glucose monitoring device market. The continuous evolution of technology has led to the development of innovative and sophisticated monitoring solutions that offer enhanced accuracy, convenience, and user-friendliness. Notably, the introduction of wearable devices and non-invasive monitoring technologies has revolutionized the landscape of glucose monitoring.

Wearable glucose monitoring devices, such as continuous glucose monitoring (CGM) systems, provide real-time data on blood glucose levels, allowing individuals with diabetes to make informed decisions about their lifestyle and treatment regimens. These devices often come in the form of patches or sensors that can be discreetly worn on the body, offering a seamless and non-disruptive monitoring experience.

Non-invasive glucose monitoring technologies, which eliminate the need for traditional fingerstick methods, have gained prominence for their potential to enhance patient comfort and compliance. These technologies may use methods like optical sensing or breath analysis to measure glucose levels without the need for needles.

The integration of advanced technologies not only improves the accuracy of glucose monitoring but also contributes to the overall adoption of monitoring devices by making them more user-friendly. As technology continues to advance, the glucose monitoring device market is poised to witness further innovation, driving improvements in diabetes management and patient outcomes.

Remote Patient Monitoring

The growing trend of remote patient monitoring is a significant factor influencing the expansion of the glucose monitoring device market. Remote patient monitoring involves the use of technology to collect and transmit health data from patients to healthcare providers without the need for in-person visits. In the context of glucose monitoring, this trend has been particularly impactful for individuals with diabetes.

Glucose monitoring devices that support remote patient monitoring enable healthcare professionals to access real-time data on patients' blood glucose levels, trends, and adherence to treatment plans. This capability fosters proactive healthcare management, allowing for timely interventions and adjustments to medication or lifestyle recommendations. The convenience of remote monitoring is especially beneficial for patients in geographically remote areas or those with mobility challenges.

The rise of telehealth services further amplifies the demand for glucose monitoring devices that facilitate remote data transmission. Patients can receive virtual consultations, and healthcare providers can make data-driven decisions based on the continuous monitoring of glucose levels. This not only improves the efficiency of healthcare delivery but also enhances patient engagement and satisfaction.

Download Free Sample Report

Key Market Challenges

Accuracy and Reliability

The challenge of ensuring the accuracy and reliability of glucose monitoring devices remains a critical concern in the diabetes management landscape. Achieving consistent and precise readings is imperative for informed decision-making by both patients and healthcare professionals. Variability in measurements or inaccuracies can lead to inappropriate adjustments in medication, potentially causing hypoglycemia or hyperglycemia.

Continuous glucose monitoring (CGM) systems, while offering valuable real-time data, face challenges related to calibration, sensor drift, and lag time. Calibration discrepancies can result in inaccurate readings, and sensor drift may cause a gradual loss of accuracy over time. Additionally, the time lag between blood glucose changes and sensor readings can impact the responsiveness of these devices.

Traditional fingerstick methods, although widely used, may also present challenges in terms of variability and discomfort for users. Factors such as inadequate blood sample size, improper technique, or environmental conditions can affect the reliability of these measurements.

Interoperability Issues

The challenge of interoperability in the glucose monitoring device market pertains to the seamless exchange and integration of data among various devices and healthcare systems. Standardization issues arise when different devices use proprietary technologies or data formats, hindering their ability to communicate and share information effectively. This lack of interoperability poses challenges for both healthcare providers and patients in achieving a comprehensive view of an individual's diabetes management.

Interoperability is crucial for integrating glucose monitoring data into broader healthcare ecosystems, including electronic health records (EHRs) and other telehealth platforms. Without standardized interfaces and data formats, the flow of information between devices and systems may be fragmented, leading to inefficiencies in care coordination and decision-making.

The push for interoperability involves efforts to establish common standards and protocols, allowing glucose monitoring devices to communicate seamlessly with other components of the healthcare infrastructure. Achieving interoperability not only enhances data accessibility for healthcare professionals but also empowers patients to share their glucose data with various healthcare providers regardless of the specific monitoring device they use.

Key Market Trends

Wearable Technology Integration

The integration of glucose monitoring with wearable technology represents a significant trend in the healthcare landscape. This trend involves the incorporation of glucose monitoring capabilities into devices such as smartwatches, fitness trackers, and other wearable gadgets. This integration offers several advantages, contributing to the increased adoption of glucose monitoring devices.

Wearable glucose monitors provide users with continuous and real-time data on their blood glucose levels, enhancing awareness and enabling proactive management of diabetes. The convenience of having this information readily available on a device that individuals typically wear regularly promotes better adherence to monitoring routines.

Moreover, the combination of glucose monitoring with wearable technology aligns with the broader movement toward a more holistic approach to health and wellness. Users can track not only their glucose levels but also other relevant health metrics, fostering a more comprehensive understanding of their overall well-being.

The trend also supports the notion of patient empowerment, as individuals gain more control and insight into their health data. Wearable devices often come equipped with user-friendly interfaces and connectivity features, allowing seamless data sharing with healthcare providers, thereby facilitating more informed and collaborative decision-making in diabetes management. As technology continues to advance, this integration is likely to play a pivotal role in transforming how individuals monitor and manage their diabetes on a day-to-day basis.

Artificial Intelligence and Data Analytics

The trend of incorporating data analytics into glucose monitoring involves leveraging advanced analytical techniques to derive valuable insights from the vast amount of data generated by monitoring devices. This trend signifies a shift from simply collecting data to extracting meaningful patterns, trends, and actionable information, ultimately enhancing the effectiveness of diabetes management.

Data analytics in glucose monitoring encompasses the application of statistical analysis, machine learning algorithms, and artificial intelligence to interpret glucose data. By analyzing patterns in blood glucose levels over time, these techniques can help identify trends, potential risk factors, and correlations that may not be immediately apparent to healthcare professionals or individuals with diabetes.

The integration of data analytics enables personalized medicine by tailoring treatment plans based on individual patient data. Predictive analytics may help forecast potential glucose fluctuations, allowing for proactive adjustments to medication, diet, or lifestyle. Additionally, analytics can contribute to the development of algorithms that optimize insulin delivery, improving the precision and efficacy of diabetes management.

Segmental Insights

Product Type Insights

Based on the Product type, Self-Monitoring Device, has emerged as the dominant in the Global Glucose Monitoring Device Market. Self-monitoring devices have emerged as the dominant product type in the Global Glucose Monitoring Device Market due to several key factors. These devices, which empower individuals to monitor their blood glucose levels independently, offer a user-centric approach to diabetes management. The rise in the prevalence of diabetes has underscored the importance of regular monitoring, and self-monitoring devices provide a convenient and accessible solution for patients. The ease of use and portability of these devices allow individuals to check their glucose levels at home or on the go, promoting a proactive approach to diabetes care.

Moreover, advancements in technology have significantly enhanced the features of self-monitoring devices, making them more accurate, user-friendly, and capable of providing real-time data. Patients appreciate the convenience and immediate feedback offered by these devices, facilitating quicker decision-making regarding dietary choices, medication adjustments, and overall lifestyle modifications. The trend towards patient empowerment and the growing emphasis on personalized medicine further support the dominance of self-monitoring devices, aligning with the broader movement in healthcare towards putting individuals in control of their health. As a result, the market for self-monitoring devices is expected to continue its growth trajectory, driven by the increasing demand for effective, user-friendly solutions in the dynamic landscape of diabetes management.

Application Insights

Type 2 Diabetes has emerged as the dominant solution in the global Glucose Monitoring Device market, owing to several compelling factors. Type 2 Diabetes has asserted its dominance as the primary application in the global Glucose Monitoring Device market due to a confluence of compelling factors. Firstly, the sheer prevalence of Type 2 Diabetes on a global scale has elevated the demand for glucose monitoring devices tailored to address the unique characteristics of this form of diabetes. The rising incidence is often attributed to lifestyle factors, including sedentary behavior, unhealthy dietary patterns, and obesity. As a result, individuals with Type 2 Diabetes require consistent and effective glucose monitoring to manage their condition optimally.

Secondly, the progressive nature of Type 2 Diabetes, which often involves insulin resistance and impaired glucose regulation, necessitates regular monitoring to make timely adjustments in treatment plans. Glucose monitoring devices, ranging from traditional fingerstick devices to advanced continuous glucose monitoring systems, play a pivotal role in helping patients and healthcare professionals track fluctuations in blood glucose levels.

Download Free Sample Report

Regional Insights

North America presently stands as the dominant force in the global Glucose Monitoring Device market, a position fortified by a convergence of influential factors. Firstly, the region's high prevalence of diabetes, particularly Type 2 Diabetes, has fueled an increased demand for advanced glucose monitoring solutions. The sedentary lifestyle, dietary habits, and a growing aging population contribute to the elevated incidence of diabetes, compelling individuals to seek effective monitoring tools.

Secondly, the robust healthcare infrastructure and accessibility to advanced technologies in North America facilitate the adoption of innovative glucose monitoring devices. The region's healthcare system is characterized by a proactive approach to chronic disease management, with an emphasis on integrating cutting-edge technologies into patient care.

Thirdly, favorable reimbursement policies and insurance coverage for glucose monitoring devices encourage widespread adoption. The financial support provided by insurance schemes alleviates the economic burden on patients, fostering increased acceptance and utilization of these devices.

Moreover, North America is at the forefront of technological advancements in healthcare, with continuous research and development initiatives contributing to the introduction of sophisticated monitoring devices. The presence of key market players and their focus on product innovation further cements North America's dominance in the global Glucose Monitoring Device market, making it a hub for advancements that positively impact diabetes management.

Recent Developments

In October 2023, the Canadian government granted approval for the Dexcom G7 Continuous Glucose Monitoring System, the next-generation product by Dexcom. This approval allows Dexcom to introduce its advanced monitoring system to the Canadian market, catering specifically to individuals with type-1 diabetes.
In June 2023, the South Korean Ministry of Food and Drug Safety granted approval for the inaugural domestically manufactured continuous glucose monitoring (CGM) device. I-SENS, a prominent manufacturer of blood glucose devices, unveiled CareSens Air as the latest addition to their product line. CareSens Air is positioned as the most compact and lightweight CGM device available in the South Korean market.

Key Market Players

Abbott Laboratories, Inc
Dexcom, Inc
F. Hoffmann-La Roche AG
Medtronic plc
Ascensia Diabetes Care Holdings AG
Sinocare Inc
Nemaura Medical Inc
Nipro Corporation
ARKRAY, Inc
Senseonics Holdings, Inc
B. Braun Medical Inc
LifeScan Inc
Prodigy Diabetes Care LLC
Nova Biomedical Corp
DiaMonTech GmbH
AgaMatrix Inc
Bionime Corporation
Acon Laboratories Inc
Medisana AG
Rossmax International Ltd

By Product Type

By Application

By End User

By Region

Self-Monitoring Glucose Devices (Glucometers, Test Strips, Lancets)
Continuous Glucose Monitoring Devices (Sensors, Transmitters & Receivers, Integrated Insulin Pumps)

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

Home Care Settings
Hospitals
Others

North America
Europe
Asia Pacific
South America
Middle East & Africa

Report Scope:

In this report, the Global Glucose Monitoring Device Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Glucose Monitoring Device Market, By Product Type:

o Self-Monitoring Glucose Devices (Glucometers, Test Strips, Lancets)

o Continuous Glucose Monitoring Devices (Sensors, Transmitters & Receivers, Integrated Insulin Pumps)

Glucose Monitoring Device Market, By Application:

o Type 1 Diabetes

o Type 2 Diabetes

o Gestational Diabetes

Glucose Monitoring Device Market, By End User:

o Home Care Settings

o Hospitals

o Others

Glucose Monitoring Device Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ United Kingdom

§ Italy

§ Germany

§ Spain

o Asia-Pacific

§ China

§ India

§ Japan

§ Australia

§ South Korea

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Glucose Monitoring Device Market.

Available Customizations:

Global Glucose Monitoring Device market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Glucose Monitoring Device Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validations

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Global Glucose Monitoring Device Market Outlook

4.1. Market Size & Forecast

4.1.1. By Value

4.2. Market Share & Forecast

4.2.1. By Product Type {Self-Monitoring Glucose Devices (Glucometers, Test Strips, Lancets) and Continuous Glucose Monitoring Devices (Sensors, Transmitters & Receivers, Integrated Insulin Pumps)}

4.2.2. By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes)

4.2.3. By End User (Home Care Settings, Hospitals, Others)

4.2.4. By Region

4.2.5. By Company (2023)

4.3. Market Map

5. North America Glucose Monitoring Device Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product Type

5.2.2. By Application

5.2.3. By End User

5.2.4. By Country

5.3. North America: Country Analysis

5.3.1. United States Glucose Monitoring Device Market Outlook

5.3.1.1. Market Size & Forecast

5.3.1.1.1. By Value

5.3.1.2. Market Share & Forecast

5.3.1.2.1. By Product Type

5.3.1.2.2. By Application

5.3.1.2.3. By End User

5.3.2. Canada Glucose Monitoring Device Market Outlook

5.3.2.1. Market Size & Forecast

5.3.2.1.1. By Value

5.3.2.2. Market Share & Forecast

5.3.2.2.1. By Product Type

5.3.2.2.2. By Application

5.3.2.2.3. By End User

5.3.3. Mexico Glucose Monitoring Device Market Outlook

5.3.3.1. Market Size & Forecast

5.3.3.1.1. By Value

5.3.3.2. Market Share & Forecast

5.3.3.2.1. By Product Type

5.3.3.2.2. By Application

5.3.3.2.3. By End User

6. Europe Glucose Monitoring Device Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type

6.2.2. By Application

6.2.3. By End User

6.2.4. By Country

6.3. Europe: Country Analysis

6.3.1. Germany Glucose Monitoring Device Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product Type

6.3.1.2.2. By Application

6.3.1.2.3. By End User

6.3.2. United Kingdom Glucose Monitoring Device Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product Type

6.3.2.2.2. By Application

6.3.2.2.3. By End User

6.3.3. Italy Glucose Monitoring Device Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product Type

6.3.3.2.2. By Application

6.3.3.2.3. By End User

6.3.4. France Glucose Monitoring Device Market Outlook

6.3.4.1. Market Size & Forecast

6.3.4.1.1. By Value

6.3.4.2. Market Share & Forecast

6.3.4.2.1. By Product Type

6.3.4.2.2. By Application

6.3.4.2.3. By End User

6.3.5. Spain Glucose Monitoring Device Market Outlook

6.3.5.1. Market Size & Forecast

6.3.5.1.1. By Value

6.3.5.2. Market Share & Forecast

6.3.5.2.1. By Product Type

6.3.5.2.2. By Application

6.3.5.2.3. By End User

7. Asia-Pacific Glucose Monitoring Device Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Application

7.2.3. By End User

7.2.4. By Country

7.3. Asia-Pacific: Country Analysis

7.3.1. China Glucose Monitoring Device Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product Type

7.3.1.2.2. By Application

7.3.1.2.3. By End User

7.3.2. India Glucose Monitoring Device Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product Type

7.3.2.2.2. By Application

7.3.2.2.3. By End User

7.3.3. Japan Glucose Monitoring Device Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product Type

7.3.3.2.2. By Application

7.3.3.2.3. By End User

7.3.4. South Korea Glucose Monitoring Device Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product Type

7.3.4.2.2. By Application

7.3.4.2.3. By End User

7.3.5. Australia Glucose Monitoring Device Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product Type

7.3.5.2.2. By Application

7.3.5.2.3. By End User

8. South America Glucose Monitoring Device Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Application

8.2.3. By End User

8.2.4. By Country

8.3. South America: Country Analysis

8.3.1. Brazil Glucose Monitoring Device Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product Type

8.3.1.2.2. By Application

8.3.1.2.3. By End User

8.3.2. Argentina Glucose Monitoring Device Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product Type

8.3.2.2.2. By Application

8.3.2.2.3. By End User

8.3.3. Colombia Glucose Monitoring Device Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product Type

8.3.3.2.2. By Application

8.3.3.2.3. By End User

9. Middle East and Africa Glucose Monitoring Device Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product Type

9.2.2. By Application

9.2.3. By End User

9.2.4. By Country

9.3. MEA: Country Analysis

9.3.1. South Africa Glucose Monitoring Device Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product Type

9.3.1.2.2. By Application

9.3.1.2.3. By End User

9.3.2. Saudi Arabia Glucose Monitoring Device Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product Type

9.3.2.2.2. By Application

9.3.2.2.3. By End User

9.3.3. UAE Glucose Monitoring Device Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product Type

9.3.3.2.2. By Application

9.3.3.2.3. By End User

10. Market Dynamics

10.1. Drivers

10.2. Challenges

11. Market Trends & Developments

11.1. Recent Development

11.2. Mergers & Acquisitions

11.3. Product Launches

12. Global Glucose Monitoring Device Market: SWOT Analysis

13. Porter’s Five Forces Analysis

13.1. Competition in the Industry

13.2. Potential of New Entrants

13.3. Power of Suppliers

13.4. Power of Customers

13.5. Threat of Substitute Products

14. Competitive Landscape

14.1. Abbott Laboratories, Inc

14.1.1. Business Overview

14.1.2. Service Offerings

14.1.3. Recent Developments

14.1.4. Key Personnel

14.1.5. SWOT Analysis

14.2. Dexcom, Inc

14.3. F. Hoffmann-La Roche AG

14.4. Medtronic plc

14.5. Ascensia Diabetes Care Holdings AG

14.6. Sinocare Inc

14.7. Nemaura Medical Inc

14.8. Nipro Corporation

14.9. ARKRAY, Inc

14.10. Senseonics Holdings, Inc

14.11. B. Braun Medical Inc

14.12. LifeScan Inc

14.13. Prodigy Diabetes Care LLC

14.14. Nova Biomedical Corp

14.15. DiaMonTech GmbH

14.16. AgaMatrix Inc

14.17. Bionime Corporation

14.18. Acon Laboratories Inc

14.19. Medisana AG

14.20. Rossmax International Ltd

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Figure 1: Global Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 2: Global Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 3: Global Blood Glucose Monitoring Devices Market Share, By Product Type, By Self-Monitoring Glucose Devices, By Value, 2019-2029F

Figure 4: Global Blood Glucose Monitoring Devices Market Share, By Product Type, By Continuous Glucose Monitoring Devices, By Value, 2019-2029F

Figure 5: Global Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 6: Global Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 7: Global Blood Glucose Monitoring Devices Market Share, By Region, By Value, 2019-2029F

Figure 8: Global Blood Glucose Monitoring Devices Market Share, By Company, By Value, 2023

Figure 9: Global Blood Glucose Monitoring Devices Market Map, By Product Type, Market Size (USD Billion) & Growth Rate (%), 2023

Figure 10: Global Blood Glucose Monitoring Devices Market Map, By Application, Market Size (USD Billion) & Growth Rate (%), 2023

Figure 11: Global Blood Glucose Monitoring Devices Market Map, By End User, Market Size (USD Billion) & Growth Rate (%), 2023

Figure 12: Global Blood Glucose Monitoring Devices Market Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2023

Figure 13: North America Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 14: North America Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 15: North America Blood Glucose Monitoring Devices Market Share, By Product Type, By Self-Monitoring Glucose Devices, By Value, 2019-2029F

Figure 16: North America Blood Glucose Monitoring Devices Market Share, By Product Type, By Continuous Glucose Monitoring Devices, By Value, 2019-2029F

Figure 17 North America Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 18: North America Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 19: North America Blood Glucose Monitoring Devices Market Share, By Country, By Value, 2019-2029F

Figure 20: United States Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 21: United States Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 22: United States Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 23: United States Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 24: Mexico Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 25: Mexico Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 26: Mexico Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 27: Mexico Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 28: Canada Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 29: Canada Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 30: Canada Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 31: Canada Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 32: Asia Pacific Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 33: Asia Pacific Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 34: Asia Pacific Blood Glucose Monitoring Devices Market Share, By Product Type, By Self-Monitoring Glucose Devices, By Value, 2019-2029F

Figure 35: Asia Pacific Blood Glucose Monitoring Devices Market Share, By Product Type, By Continuous Glucose Monitoring Devices, By Value, 2019-2029F

Figure 36: Asia Pacific Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 37: Asia Pacific Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 38: Asia Pacific Blood Glucose Monitoring Devices Market Share, By Country, By Value, 2019-2029F

Figure 39: China Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 40: China Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 41: China Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 42: China Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 43: India Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 44: India Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 45: India Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 46: India Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 47: Japan Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 48: Japan Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 49: Japan Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 50: Japan Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 51: Australia Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 52: Australia Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 53: Australia Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 54: Australia Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 55: South Korea Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 56: South Korea Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 57: South Korea Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 58: South Korea Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 59: Europe Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 60: Europe Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 61: Europe Blood Glucose Monitoring Devices Market Share, By Product Type, By Self-Monitoring Glucose Devices, By Value, 2019-2029F

Figure 62: Europe Blood Glucose Monitoring Devices Market Share, By Product Type, By Continuous Glucose Monitoring Devices, By Value, 2019-2029F

Figure 63: Europe Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 64: Europe Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 65: Europe Blood Glucose Monitoring Devices Market Share, By Country, By Value, 2019-2029F

Figure 66: Germany Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 67: Germany Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 68: Germany Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 69: Germany Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 70: Spain Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 71: Spain Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 72: Spain Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 73: Spain Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 74: Italy Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 75: Italy Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 76: Italy Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 77: Italy Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 78: France Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 79: France Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 80: France Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 81: France Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 82: United Kingdom Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 83: United Kingdom Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 84: United Kingdom Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 85: United Kingdom Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 86: South America Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 87: South America Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 88: South America Blood Glucose Monitoring Devices Market Share, By Product Type, By Self-Monitoring Glucose Devices, By Value, 2019-2029F

Figure 89: South America Blood Glucose Monitoring Devices Market Share, By Product Type, By Continuous Glucose Monitoring Devices, By Value, 2019-2029F

Figure 90: South America Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 91: South America Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 92: South America Blood Glucose Monitoring Devices Market Share, By Country, By Value, 2019-2029F

Figure 93: Brazil Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 94: Brazil Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 95: Brazil Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 96: Brazil Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 97: Argentina Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 98: Argentina Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 99: Argentina Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 100: Argentina Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 101: Colombia Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 102: Colombia Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 103: Colombia Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 104: Colombia Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 105: Middle East & Africa Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 106: Middle East & Africa Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 107: Middle East & Africa Blood Glucose Monitoring Devices Market Share, By Product Type, By Self-Monitoring Glucose Devices, By Value, 2019-2029F

Figure 108: Middle East & Africa Blood Glucose Monitoring Devices Market Share, By Product Type, By Continuous Glucose Monitoring Devices, By Value, 2019-2029F

Figure 109: Middle East & Africa Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 110: Middle East & Africa Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 111: Middle East & Africa Blood Glucose Monitoring Devices Market Share, By Country, By Value, 2019-2029F

Figure 112: South Africa Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 113: South Africa Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 114: South Africa Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 115: South Africa Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 116: Saudi Arabia Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 117: Saudi Arabia Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 118: Saudi Arabia Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 119: Saudi Arabia Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Figure 120: UAE Blood Glucose Monitoring Devices Market Size, By Value (USD Billion), 2019-2029F

Figure 121: UAE Blood Glucose Monitoring Devices Market Share, By Product Type, By Value, 2019-2029F

Figure 122: UAE Blood Glucose Monitoring Devices Market Share, By Application, By Value, 2019-2029F

Figure 123: UAE Blood Glucose Monitoring Devices Market Share, By End User, By Value, 2019-2029F

Frequently asked questions

What was the market size of the Global Glucose Monitoring Device Market in 2023?

The market size of the Global Glucose Monitoring Device Market was estimated to be USD 18.88 Billion in 2023.

Which was the dominant segment by Product Type in the Global Glucose Monitoring Device Market in 2023?

Self-monitoring devices have secured their position as the leading product type in the Global Glucose Monitoring Device Market for several compelling reasons. Firstly, these devices empower individuals with diabetes to actively participate in the management of their condition by providing a user-friendly and accessible means of monitoring blood glucose levels. The emphasis on patient-centric care and the growing trend of patient empowerment align with the convenience and autonomy offered by self-monitoring devices.

Which is the dominant region in the Global Glucose Monitoring Device Market?

North America's dominance in the global Glucose Monitoring Device market can be attributed to its forefront position in several critical aspects. Firstly, the region excels in technological innovation and research and development initiatives, consistently producing cutting-edge glucose monitoring devices. This innovation is driven by a strong collaboration between the healthcare industry and technology developers, resulting in the introduction of advanced and effective monitoring solutions.

What are the major drivers for the Global Glucose Monitoring Device Market?

Increasing prevalence of diabetes and technological advancements are factors driving the Global Glucose Monitoring Device market in the forecast period 2024-2029.

Buy Now